Lecanemab (also known as Leqembi) has made headlines as the first drug ever approved in the UK by the MHRA that can slow down early-stage Alzheimer’s disease but it has not been recommended for use in the NHS at this stage. Here is what we know so far about this breakthrough Alzheimer's drug.
You searched for 'to of dementia':
Showing 2801-2810 of about 3577
What is lecanemab?
What is lecanemab? .Lecanemab (also known as Leqembi) has made headlines as the first drug ever approved in the UK by the MHRA that can slow down early-stage Alzheimer’s disease but it has not been recommended for use in the NHS at this stage. Here is what we know so far about this breakthrough Alzheimer's drug.
Love to move: Enjoying company and activities
Love to move: Enjoying company and activities .Crisis in care at home 'leads to rising hospital admissions among elderly'
Crisis in care at home 'leads to rising hospital admissions among elderly' .Research news in brief Spring 2018
Research news in brief Spring 2018 .Alzheimer's Society comment on disappointing results for gantenerumab drug at clinical trial
Alzheimer's Society comment on disappointing results for gantenerumab drug at clinical trial .Alzheimer's Society, study participant Eric Deeson and Sir Prof John Hardy comment on the disappointing clinical trial results for Alzheimer's drug gantenerumab.
Partnership Conferences and Events
Partnership Conferences and Events .We attend, partner and exhibit at a number of conferences and events throughout the year. View our current 2024 events with more to follow.
Sign up to our Involvement update and influence our work
Sign up to our Involvement update and influence our work .From a few minutes to regular involvement, and even activities you can do from home! We match you to opportunities to suit you. Here's what to expect.
Increase public awareness and understanding in Northern Ireland
Increase public awareness and understanding in Northern Ireland .Learn about the 5 priorities for action in Northern Ireland.